GPCR/G protein
GPCR/G protein(G 蛋白偶联受体/G 蛋白)
- Neuropeptide FF/AF Receptors(49)
- Formyl Peptide Receptors(11)
- 5-HT Receptor(504)
- Acetylcholine(29)
- Adenosine Deaminase(9)
- Adenosine Receptor(132)
- Adenosine Kinase(4)
- Adiponectin Receptor(3)
- Adrenergic Receptor(421)
- Adrenergic Transporters(5)
- Apelin Receptor(9)
- Angiotensin Receptor(114)
- Bombesin Receptors(23)
- Bradykinin Receptors(29)
- Calcitonin and Related Receptors(10)
- Cannabinoid Receptor(160)
- Calcimimetic Agent(2)
- CaSR(20)
- CCK1 Receptors(7)
- CCK2 Receptors(7)
- CCR(81)
- Chemokine Receptors(25)
- CRF1 Receptors(9)
- CRF2 Receptors(3)
- CXCR(80)
- CysLT1 receptor(1)
- Endothelin Receptor(52)
- EP1 Receptor(2)
- EP4 Receptor(3)
- ERRγ(1)
- ETA Receptors(5)
- ETB Receptors(5)
- Free Fatty Acid Receptors(18)
- Galanin Receptors(11)
- Ghrelin Receptors(12)
- GHSR(21)
- GIP Receptor(5)
- Glucagon Receptor(61)
- Glucocorticoid Receptor(97)
- GLUT1(1)
- Gonadotropin-Releasing Hormone Receptors(3)
- GPCR19(12)
- GPR109A(4)
- GPR119(10)
- GPR120(9)
- GPR35(10)
- GPR44(1)
- GPR55(11)
- Hydroxycarboxylic Acid Receptors(5)
- Leukotriene Receptor(58)
- LPA Receptor(12)
- LPL Receptor(60)
- LTD4 Receptor(1)
- mGluR (119)
- Melanin-concentrating Hormone Receptors(7)
- Melanocortin (MC) Receptors(58)
- Melatonin Receptors(24)
- Motilin Receptor(7)
- MT Receptor(1)
- Non-selective CRF(7)
- Neurotensin Receptors(24)
- NK2 Receptors(7)
- NK3 Receptor(6)
- NOP Receptor(20)
- NPY Receptors(28)
- Orexin(3)
- Orphan 7-TM Receptors(6)
- OX Receptor(48)
- Oxytocin Receptors(22)
- P2Y Receptor(62)
- PACAP Receptors(3)
- PAF Receptors(8)
- Peptide Receptors(14)
- PGD2 Receptor(1)
- Prostaglandin Receptor(172)
- Protease-Activated Receptors(10)
- Prostanoid Receptors
- RGS(2)
- S1P receptor(8)
- Secretin Receptors(1)
- Sensory Neuron-Specific Receptors(1)
- Somatostatin Receptor(39)
- Sigma Receptor(59)
- Vasopressin Receptor(35)
- 17,20-lyase(5)
- Ras(142)
- Urotensin-II Receptor(11)
- VIP Receptors(7)
- EBI2/GPR183(7)
- TSH Receptor(11)
- NK Receptor(1)
- GPR81(1)
- C3aR(1)
- CysLT2 receptor(1)
- S1P receptor inhibitor(22)
- CCKB(1)
- FFAR1 (GPR40)(20)
- GPR84(8)
- Neuromedin U Receptors(2)
- Kisspeptin Receptor(5)
- CRFR(25)
- RGS Protein(5)
- Urotensin Receptor(6)
- Cholecystokinin Receptor(25)
- GPR139(4)
- mAChR(185)
- MCHR1 (GPR24)(16)
- Neurokinin Receptor(75)
- Neuropeptide S Receptor(1)
- GPBA Receptor(1)
- Trace Amine 1 Receptor(2)
- GPCR protein(1)
- FFAR3(1)
- cGMP(27)
- GRK(1)
- GPR88
- Amylin Receptor
- Arrestin
- GCGR(2)
- GLP Receptor(2)
- Mas-related G-protein-coupled Receptor (MRGPR)
- Succinate Receptor 1
- PTHR(1)
- Protease Activated Receptor (PAR)(2)
- Free Fatty Acid Receptor(1)
- Formyl Peptide Receptor (FPR)(1)
GPCR/G protein 相关产品(3377)
- GC16312VortioxetineCAS: 508233-74-7纯度: >99.50%
Vortioxetine是一种多模式抗抑郁药,对重组人5-HT1A(K i =15nM)、5-HT1B(K i =33nM)、5-HT3A(K i =3.7nM)、5-HT7(K i =19nM)、noradrenergic β1 receptor(K i =46nM)以及SERT(K i =1.6nM)具有高亲和力。
- GC16466Rimonabant hydrochlorideCAS: 158681-13-1纯度: >99.00%
A potent and selective CB 1 receptor antagonist
- GC16523DipraglurantCAS: 872363-17-2纯度: >99.50%
Dipraglurant (ADX48621) 是一种有效的、选择性的、具有口服活性和脑渗透性的 mGluR5 负变构调节剂 (NAM),IC50 为 21 nM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC16269 | Bosentan | 147536-97-8 | >99.50% | |
An antagonist of endothelin receptors | ||||
| GC16270 | WAY-100635 maleate salt | 634908-75-1 | >98.00% | |
A serotonin 5-HT 1A antagonist | ||||
| GC16291 | Phentolamine Mesylate | 65-28-1 | >99.50% | |
A reversible α-adrenergic receptor antagonist | ||||
| GC16297 | Eprosartan Mesylate | 144143-96-4 | >99.50% | |
An angiotensin II type 1 receptor antagonist | ||||
| GC16312 | Vortioxetine | 508233-74-7 | >99.50% | |
Vortioxetine是一种多模式抗抑郁药,对重组人5-HT1A(K i =15nM)、5-HT1B(K i =33nM)、5-HT3A(K i =3.7nM)、5-HT7(K i =19nM)、noradrenergic β1 receptor(K i =46nM)以及SERT(K i =1.6nM)具有高亲和力。 | ||||
| GC16377 | SRT3190 | 1204707-73-2 | >99.00% | |
SRT3190 是 CXCR2 的拮抗剂,用于研究趋化因子介导的疾病。 | ||||
| GC16394 | PD123319 | 130663-39-7 | >98.00% | |
PD123319 是血管紧张素 II 受体的非肽类抑制剂,IC50 值为 34nM 。 | ||||
| GC16401 | L-(-)-α-Methyldopa hydrochloride | 884-39-9 | - | |
A DOPA decarboxylase inhibitor | ||||
| GC16466 | Rimonabant hydrochloride | 158681-13-1 | >99.00% | |
A potent and selective CB 1 receptor antagonist | ||||
| GC16473 | TC 1 | 362512-81-0 | - | |
σ1 receptor ligand | ||||
| GC16490 | Methyldopa | 555-30-6 | - | |
A DOPA decarboxylase inhibitor | ||||
| GC16496 | Ticlopidine | 55142-85-3 | >98.00% | |
A P2Y 12 receptor antagonist with antiplatelet activity | ||||
| GC16523 | Dipraglurant | 872363-17-2 | >99.50% | |
Dipraglurant (ADX48621) 是一种有效的、选择性的、具有口服活性和脑渗透性的 mGluR5 负变构调节剂 (NAM),IC50 为 21 nM。 | ||||
| GC16567 | CYM 5442 hydrochloride | 1783987-80-3 | >98.50% | |
A selective SIP 1 receptor agonist | ||||
| GC16619 | CTEP (RO4956371) | 871362-31-1 | >98.00% | |
A mGluR5 inverse agonist | ||||
| GC16621 | W146 | 909725-61-7 | >95.00% / >99.50% / >98.00% | |
W146是鞘氨醇-1-磷酸受体1(S1PR1)的选择性拮抗剂,EC 50 值为398nM。 | ||||
| GC16701 | SKI II | 312636-16-1 | >99.50% / >98.00% | |
An SPHK1 inhibitor | ||||
| GC16706 | AMD 3465 hexahydrobromide | 185991-07-5 | >98.00% | |
A CXCR4 receptor antagonist | ||||
| GC16708 | Cinacalcet HCl | 364782-34-3 | >99.50% | |
An allosteric agonist of the CaSR | ||||
| GC16710 | SRT3109 | 1204707-71-0 | >99.50% | |
SRT3109 是 CXCR2 的拮抗剂,pIC50 为 8.2,用于研究趋化因子介导的疾病。 | ||||
| GC16740 | Alfuzosin | 81403-80-7 | >99.50% / >99.00% | |
Alfuzosin (SL 77499-10) 是一种具有口服活性、选择性和竞争性的 α1-肾上腺素受体拮抗剂。 | ||||
| GC16772 | Cortisone acetate | 50-04-4 | >98.00% | |
A synthetic glucocorticoid | ||||
| GC16785 | Prazosin | 19216-56-9 | - | |
Prazosin是一种特异性的α1-肾上腺素能受体(α 1 -AR)的拮抗剂,与人类重组α 1A -AR、α 1B -AR和α 1D -AR的结合常数(K i 值)分别为0.2、0.25和0.32nM,与α 2 -AR的K i 值分别为340和3.7nM(在表达α 2A -AR 的 HT-29 细胞和表达α 2B -AR 的 NG108 细胞中)。 | ||||
| GC16788 | PRX-08066 Maleic acid | 866206-55-5 | - | |
5-HT2B receptor antagonist,potent and selective | ||||
